The Oncology Institute Executives to Participate in Multiple Panel Presentations at APG 2024 Spring Conference
The Oncology Institute Executives to Participate in Multiple Panel Presentations at APG 2024 Spring Conference
CERRITOS, Calif., May 22, 2024 (GLOBE NEWSWIRE) -- Today, the Oncology Institute, Inc. and its affiliates (NASDAQ: TOI) have announced their executives' participation in multiple panel presentations at the upcoming APG 2024 Spring Conference in San Diego. Chief Medical Officer, Dr. Yale Podnos, will be discussing artificial intelligence and its uses in an oncology practice in the breakout session panel "AI on the Front Lines: Improving Outcomes and Reducing Costs for Complex Patients". Dr. Daniel Virnich, Chief Executive Officer, will join other industry leaders on another panel, "Assuming Global Risk for Pharmaceuticals."
加利福尼亞州塞裏託斯，2024年5月22日（GLOBE NEWSWIRE）——今天，腫瘤研究所及其附屬公司（納斯達克股票代碼：TOI）宣佈其高管將參加即將在聖地亞哥舉行的APG 2024年春季會議的多個小組演講。首席醫學官耶魯·波德諾斯博士將在分組討論會 “人工智能前線：改善複雜患者的預後並降低成本” 的分組討論中討論人工智能及其在腫瘤學實踐中的用途。首席執行官丹尼爾·維爾尼奇博士將與其他行業領導者一起參加另一個小組討論，“假設藥品的全球風險”。
About The Oncology Institute
關於腫瘤研究所
Founded in 2007, The Oncology Institute, Inc. and its affiliates (NASDAQ: TOI) is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of more than 1.8 million patients including clinical trials, transfusions, and other care delivery models traditionally associated with the most advanced care delivery organizations. With 110+ employed clinicians and over 70 clinic locations and growing, TOI is changing oncology for the better. For more information visit www.theoncologyinstitute.com.
腫瘤學研究所及其附屬公司（納斯達克股票代碼：TOI）成立於2007年，通過在社區環境中提供高度專業化、基於價值的癌症護理來推動腫瘤學發展。TOI爲超過180萬名患者提供尖端的循證癌症護理，包括臨床試驗、輸血和傳統上與最先進的醫療服務組織相關的其他護理提供模式。TOI 擁有 110 多名臨床醫生和 70 多個診所，而且還在不斷增長，正在使腫瘤學向更好的方向發展。欲了解更多信息，請訪問 www.theoncologyinstitute。
Contacts
聯繫人
Investors at Solebury Strategic Communications
索爾伯裏戰略傳播的投資者
譯文內容由第三人軟體翻譯。